Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAC-14028 Cream in Mild to Moderate Atopic Dermatitis
NCT02757729Phase 2Completed
- Sponsor
- Amorepacific Corporation
- Start
- Oct 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of asivatrep in atopic dermatitis (AD) (4 arms), sponsored by Amorepacific Corporation. Primary endpoint: Success rate of Investigator's Global Assessment at 8 weeks. Started Oct 2015; status: completed.
02
Drugs
asivatrep
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02757729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02757729.